Get started
Author

Sharlene Litchy

Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma
2002 · John D. Hainsworth, Sharlene Litchy, et al. · Journal of Clinical Oncology · 415
Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network
2003 · John D. Hainsworth, Sharlene Litchy, et al. · Journal of Clinical Oncology · 351
Maximizing Therapeutic Benefit of Rituximab: Maintenance Therapy Versus Re-Treatment at Progression in Patients With Indolent Non-Hodgkin's Lymphoma—A Randomized Phase II Trial of the Minnie Pearl Cancer Research Network
2005 · John D. Hainsworth, Sharlene Litchy, et al. · Journal of Clinical Oncology · 330
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma
2000 · John D. Hainsworth, Howard A. Burris, et al. · Blood · 287
Phase II Trial of Paclitaxel, Carboplatin, and Etoposide in Advanced Poorly Differentiated Neuroendocrine Carcinoma: A Minnie Pearl Cancer Research Network Study
2006 · John D. Hainsworth, David R. Spigel, et al. · Journal of Clinical Oncology · 186
PDF
Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma
2000 · John D. Hainsworth, Howard A. Burris, et al. · Cancer · 136
Gemcitabine, Carboplatin, and Paclitaxel for Patients With Carcinoma of Unknown Primary Site: A Minnie Pearl Cancer Research Network Study
2002 · F. Anthony Greco, Howard A. Burris, et al. · Journal of Clinical Oncology · 116
Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium
2005 · John D. Hainsworth, Anthony A. Meluch, et al. · Cancer · 54
PDF
Carcinoma of Unknown Primary Site: Sequential Treatment with Paclitaxel/Carboplatin/Etoposide and Gemcitabine/Irinotecan: A Minnie Pearl Cancer Research Network Phase II Trial
2004 · F. Anthony Greco, Gladys I. Rodriguez, et al. · The Oncologist · 53
PDF
Rituximab Plus Short-Duration Chemotherapy As First-Line Treatment for Follicular Non-Hodgkin’s Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network
2005 · John D. Hainsworth, Sharlene Litchy, et al. · Journal of Clinical Oncology · 45
Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site
2005 · John D. Hainsworth, David R. Spigel, et al. · Cancer · 40
Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma
2002 · F. Anthony Greco, James R. Gray, et al. · Cancer · 40
PDF
Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients
2000 · John D. Hainsworth, Howard A. Burris, et al. · Cancer · 40
First-Line Treatment with Brief-Duration Chemotherapy Plus Rituximab in Elderly Patients with Intermediate-Grade Non-Hodgkin's Lymphoma: Phase II Trial
2003 · John D. Hainsworth, Sharlene Litchy, et al. · Clinical Lymphoma · 35
A Phase II Trial of Preoperative Concurrent Radiation Therapy and Weekly Paclitaxel/Carboplatin for Patients with Locally Advanced Non–Small-Cell Lung Cancer
2004 · John D. Hainsworth, James R. Gray, et al. · Clinical Lung Cancer · 10
Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma
2001 · F. Anthony Greco, Howard A. Burris, et al. · Cancer · 8
PDF
Paclitaxel/carboplatin/etoposide (PCE) therapy for advanced poorly differentiated neuroendocrine (PDNE) carcinoma: A Minnie Pearl Cancer Research Network phase II trial
2005 · F. T. Miranda, D. R. Spigel, et al. · Journal of Clinical Oncology · 4
Carcinoma of unknown primary site with unfavorable characteristics: Survival of 396 patients after treatment with five consecutive phase II trials by the Minnie Pearl Cancer Research Network
2004 · F. A. Greco, S. Litchy, et al. · Journal of Clinical Oncology · 3
Weekly docetaxel as first-line therapy for elderly patients with advanced non-small cell lung cancer (NSCLC)
2000 · J.D Hainsworth, H.A Burris, et al. · Lung Cancer · 3
Paclitaxel, Carboplatin, and Gemcitabine in the Treatment of Patients with Advanced Transitional Cell Carcinoma of the Urothelium
2006 · J.D. Hainsworth, A.A. Meluch, et al. · The Journal of Urology · 2
Gemcitabine and irinotecan in patients with previously treated carcinoma of unknown primary site: A Minnie Pearl Cancer Research Network phase II trial
2004 · H. H. Doss, J. D. Hainsworth, et al. · Journal of Clinical Oncology · 2
First-line treatment with single agent rituximab, followed by maintenance rituximab plus anti-idiotype Id-KLH active immunotherapy vaccine (FavId) in patients (pts) with low-grade non-Hodgkin lymphoma (NHL): Preliminary results of a phase II trial
2007 · E. Raefsky, F. A. Greco, et al. · Journal of Clinical Oncology · 1
Preoperative gemcitabine (G) and docetaxel (D) in patients (pts) with stage IB, II, or III non-small cell lung cancer (NSCLC): A phase II trial of the Minnie Pearl Cancer Research Network
2006 · D. R. Spigel, J. D. Hainsworth, et al. · Journal of Clinical Oncology · 1
Adjuvant paclitaxel (P)/carboplatin (C) in stages I, II non-small cell lung cancer (NSCLC): Comparison of two schedules in phase II trials by the Minnie Pearl Cancer Research Network
2005 · C. E. McKay, J. D. Hainsworth, et al. · Journal of Clinical Oncology · 1
Works count: 24
Citation count: 2,163
H-index: 14
I10-index: 15
Year
Topic
Type